First Merchants Corp’s AstraZeneca AZN Stock Holding History

First Merchants Corp’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-48,709	Closed	-$8.96M	–	361
2025 Q4	$8.96M	Buy	48,709 +763	+2%	+$134K	0.33%	74
2025 Q3	$7.36M	Sell	47,946 -871	-2%	-$132K	0.28%	87
2025 Q2	$6.82M	Buy	48,817 +522	+1%	+$73.2K	0.26%	94
2025 Q1	$7.1M	Buy	48,295 +14,835	+44%	+$2.15M	0.28%	95
2024 Q4	$4.38M	Buy	33,460 +66	+0.2%	+$9.24K	0.17%	126
2024 Q3	$5.2M	Buy	33,394 +214	+0.6%	+$34.5K	0.2%	119
2024 Q2	$5.18M	Buy	33,180 +2,750	+9%	+$414K	0.21%	117
2024 Q1	$4.12M	Buy	30,430 +1,535	+5%	+$203K	0.31%	95
2023 Q4	$3.89M	Buy	+28,895	New	+$3.76M	0.32%	96

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

First Merchants Corp's AZN Position: Q1 2026 in Review

First Merchants Corp sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 48,709 shares — an estimated $8.96M sold.

First Merchants Corp first reported a position in AZN in Q4 2023 and held it in 9 quarters. The position peaked at $8.96M in Q4 2025. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

First Merchants Corp reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
First Merchants Corp sold 48,709 AstraZeneca shares in Q1 2026, an estimated $8.96M.
First Merchants Corp first reported a position in AstraZeneca in Q4 2023 and held it in 9 quarters.
First Merchants Corp's AstraZeneca position peaked at $8.96M in Q4 2025.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on First Merchants Corp's 13F filing for Q1 2026, filed 16 Apr 2026.